EIM
REGN icon

ExxonMobil Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

ExxonMobil Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$4.07M Sell
11,822
-427
-3% -$149K 0.12% 200
2017
Q4 		$4.61M Sell
12,249
-1,781
-13% -$721K 0.13% 187
2017
Q3 		$6.27M Sell
14,030
-600
-4% -$286K 0.16% 153
2017
Q2 		$7.18M Sell
14,630
-2,257
-13% -$988K 0.18% 136
2017
Q1 		$6.54M Sell
16,887
-611
-3% -$226K 0.14% 170
2016
Q4 		$6.42M Sell
17,498
-1,772
-9% -$674K 0.14% 173
2016
Q3 		$7.75M Sell
19,270
-920
-5% -$369K 0.16% 152
2016
Q2 		$7.05M Buy
20,190
+1,180
+6% +$454K 0.15% 158
2016
Q1 		$6.85M Buy
19,010
+1,609
+9% +$663K 0.16% 153
2015
Q4 		$9.45M Sell
17,401
-349
-2% -$189K 0.23% 103
2015
Q3 		$8.26M Buy
17,750
+1,013
+6% +$544K 0.21% 116
2015
Q2 		$8.54M Sell
16,737
-1,004
-6% -$490K 0.21% 122
2015
Q1 		$8.01M Buy
17,741
+244
+1% +$103K 0.18% 138
2014
Q4 		$7.18M Sell
17,497
-582
-3% -$229K 0.17% 149
2014
Q3 		$6.52M Sell
18,079
-2,197
-11% -$736K 0.15% 162
2014
Q2 		$5.73M Sell
20,276
-349
-2% -$103K 0.13% 192
2014
Q1 		$6.19M Buy
20,625
+180
+0.9% +$55.5K 0.14% 179
2013
Q4 		$5.63M Sell
20,445
-295
-1% -$84.8K 0.13% 190
2013
Q3 		$6.49M Sell
20,740
-485
-2% -$128K 0.16% 148
2013
Q2 		$4.77M Buy
+21,225
New +$4.94M 0.12% 202

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

ExxonMobil Investment Management's REGN Position: Q1 2018 in Review

ExxonMobil Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 3.5% in Q1 2018, selling an estimated $149K and leaving 11,822 shares worth $4.07M. The position accounts for 0.12% of the portfolio, ranked #200.

ExxonMobil Investment Management first reported a position in REGN in Q2 2013 and has held it in 20 quarters since. The position peaked at $9.45M in Q4 2015. 620 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • ExxonMobil Investment Management held 11,822 shares of Regeneron Pharmaceuticals worth $4.07M as of Q1 2018.
  • ExxonMobil Investment Management sold 427 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $149K.
  • Regeneron Pharmaceuticals made up 0.12% of ExxonMobil Investment Management's portfolio in Q1 2018, its #200 holding.
  • ExxonMobil Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
  • ExxonMobil Investment Management's Regeneron Pharmaceuticals position peaked at $9.45M in Q4 2015.
  • 620 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on ExxonMobil Investment Management's 13F filing for Q1 2018, filed 12 Apr 2018.